Ginkgo biloba extract enhances glucose tolerance in hyperinsulinism-induced hepatic cells

Journal of Natural Medicines

Volumn 65, Issue 1, 2011, Pages 50-56

  Zhou, Lei ^a   Meng, Qingjie ^a   Qian, Tao ^a   Yang, Zaiqing ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Diabetes; Hepatocytes; Herb; Insulin resistance; Thiazolidinedione

Indexed keywords

GINKGO BILOBA EXTRACT; GLUCOKINASE; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 2; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HYPERINSULINISM; LIVER CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELL LINE; GINKGO BILOBA; GLUCOKINASE; GLUCOSE; GLUCOSE-6-PHOSPHATASE; HEPATOCYTES; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; PLANT EXTRACTS; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAZOLIDINEDIONES;

EID: 78651380659     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-010-0456-z     Document Type: Article

References (29)

1. R Della Loggia S Sosa A Tubaro P Morazzoni E Bombardelli A Griffini 1996 Anti-inflammatory activity of some Ginkgo biloba constituents and of their phospholipid-complexes Fitoterapia 67 257 264 1:CAS:528:DyaK28XlsFSltLo%3D
2. ME Omar AR Baiuomy S El-Batran MS Arbid 2004 Evaluation of the anti-inflammatory, anti-nociceptive and gastric effects of Ginkgo biloba in the rat Pharmacol Res 49 133 142 10.1016/j.phrs.2003.08.004 (Pubitemid 37492865)
3. E Bombardelli A Cristoni SB Curri 1996 Activity of phospholipid-complex of Ginkgo biloba dimeric flavonoids on the skin microcirculation Fitoterapia 67 265 273 1:CAS:528:DyaK28XlsFSltLs%3D
4. R Saponara E Bosisio 1998 Inhibition of cAMP-phosphodiesterase by biflavones of Ginkgo biloba in rat adipose tissue J Nat Prod 61 1386 1387 1:CAS:528:DyaK1cXmtF2htbo%3D 9834158 10.1021/np970569m (Pubitemid 28555104)
5. M Dell'Agli E Bosisio 2002 Biflavones of Ginkgo biloba stimulate lipolysis in 3T3-L1 adipocytes Planta Med 68 76 79 11842336 10.1055/s-2002-19876 (Pubitemid 34113597)
6. AD Boveris A Galatro S Puntarulo 2000 Effect of nitric oxide and plant antioxidants on microsomal content of lipid radicals Biol Res 33 159 165 1:CAS:528:DC%2BD3MXhtVamtr8%3D 15693283 10.4067/S0716-97602000000200016
7. H Nian B Song W Wang 2004 Antioxidative stress effect of Ginkgo biloba extract to experimental diabetes rats J Mudanjiang Med Coll 25 3 6
8. Z Wei Q Peng BH Lau V Shah 1999 Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells Gen Pharmacol 33 369 375 1:CAS:528:DyaK1MXns1GhsbY%3D 10553877 10.1016/S0306-3623(99)00027-0 (Pubitemid 29507455)
9. I Maitra L Marcocci MT Droy-Lefaix L Packer 1995 Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761 Biochem Pharmacol 49 1649 1655 1:CAS:528:DyaK2MXmt1ShsLo%3D 7786306 10.1016/0006-2952(95)00089-I
10. J Bernardczyk-Meller J Siwiec-Proscinska W Stankiewicz P Fichna K Pecold E Korman 2004 Influence of Eqb 761 on the function of the retina in children and adolescent with long lasting diabetes mellitus - preliminary report Klin Oczna 106 569 571 15646470
11. GI Bell T Kayano JB Buse CF Burant J Takeda D Lin H Fukumoto S Seino 1990 Molecular biology of mammalian glucose transporters Diabetes Care 13 198 208 1:STN:280:DyaK3c7mvVGktw%3D%3D 2407475 10.2337/diacare.13.3.198
12. RA Memon LH Tecott K Nonogaki A Beigneux AH Moser C Grunfeld KR Feingold 2000 Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice Endocrinology 141 4021 4031 1:CAS:528:DC%2BD3cXnslKhurw%3D 11089532 10.1210/en.141.11.4021
13. JD Horton JL Goldstein MS Brown 2002 SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J Clin Invest 109 1125 1131 1:CAS:528:DC%2BD38XjsFals7c%3D 11994399
14. ME Patti XJ Sun JC Bruening E Araki MA Lipes MF White CR Kahn 1995 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice J Biol Chem 270 24670 24673 1:CAS:528:DyaK2MXovFWnurw%3D 7559579 10.1074/jbc.270.42.24670
15. KI Rother Y Imai M Caruso F Beguinot P Formisano D Accili 1998 Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes J Biol Chem 273 17491 17497 1:CAS:528:DyaK1cXkvFarsro%3D 9651339 10.1074/jbc.273.28. 17491 (Pubitemid 28355081)
16. H Yeh T Chu T Shen 1980 Ultrastructure of continuously cultured adult human liver cell Acta Biol Exp Sin 13 361 364
17. C Li G Ning J Chen 1999 Establishing and identifying insulin-resistant HepG2 cell line Chin J Diabetes 7 198 200
18. WT Garvey JM Olefsky S Marshall 1985 Insulin receptor down-regulation is linked to an insulin-induced postreceptor defect in the glucose transport system in rat adipocytes J Clin Invest 76 22 30 1:CAS:528:DyaL2MXkvF2is74%3D 3894420 10.1172/JCI111950
19. PR Pryor SC Liu AE Clark J Yang GD Holman D Tosh 2000 Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin Biochem J 348 Pt 1 83 91 1:STN:280:DC%2BD3c3ls1OltQ%3D%3D 10794717 10.1042/0264-6021:3480083 (Pubitemid 30312134)
20. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 1:CAS:528:DyaE28XksVehtrY%3D 942051 10.1016/0003- 2697(76)90527-3
21. C Fernandez-Mejia J Vega-Allende A Rojas-Ochoa M Rodriguez-Dorantes G Romero-Navarro FM Matschinsky J Wang MS German 2001 Cyclic adenosine 3′,5′-monophosphate increases pancreatic glucokinase activity and gene expression Endocrinology 142 1448 1452 1:CAS:528:DC%2BD3MXitlemtbo%3D 11250924 10.1210/en.142.4.1448 (Pubitemid 32299672)
22. H Yki-Jarvinen 2004 Thiazolidinediones N Engl J Med 351 1106 1118 15356308 10.1056/NEJMra041001 (Pubitemid 39167514)
23. Y Miyazaki H He LJ Mandarino RA DeFronzo 2003 Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients Diabetes 52 1943 1950 1:CAS:528:DC%2BD3sXlvFCgt74%3D 12882909 10.2337/diabetes.52.8.1943 (Pubitemid 36919785)
24. Y Mori Y Murakawa K Okada H Horikoshi J Yokoyama N Tajima Y Ikeda 1999 Effect of troglitazone on body fat distribution in type 2 diabetic patients Diabetes Care 22 908 912 1:STN:280:DyaK1MzgtVyhug%3D%3D 10372240 10.2337/diacare.22.6.908 (Pubitemid 29241043)
25. GB Kudolo 2000 The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic beta-cell function in response to glucose loading in normal glucose tolerant individuals J Clin Pharmacol 40 647 654 1:CAS:528: DC%2BD3cXktFCqt7w%3D 10868316 10.1177/00912700022009297
26. CM Taniguchi K Ueki R Kahn 2005 Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism J Clin Invest 115 718 727 1:CAS:528:DC%2BD2MXit1emt78%3D 15711641
27. N Kubota K Tobe Y Terauchi K Eto T Yamauchi R Suzuki Y Tsubamoto K Komeda R Nakano H Miki S Satoh H Sekihara S Sciacchitano M Lesniak S Aizawa R Nagai S Kimura Y Akanuma SI Taylor T Kadowaki 2000 Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia Diabetes 49 1880 1889 1:CAS:528: DC%2BD3cXnvVOmt7g%3D 11078455 10.2337/diabetes.49.11.1880
28. T Ide H Shimano N Yahagi T Matsuzaka M Nakakuki T Yamamoto Y Nakagawa A Takahashi H Suzuki H Sone H Toyoshima A Fukamizu N Yamada 2004 SREBPs suppress IRS-2-mediated insulin signalling in the liver Nat Cell Biol 6 351 357 1:CAS:528:DC%2BD2cXis1GltLg%3D 15048126 10.1038/ncb1111 (Pubitemid 38584825)
29. YS Lee BY Cha K Saito H Yamakawa SS Choi K Yamaguchi T Yonezawa T Teruya K Nagai JT Woo 2010 Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice Biochem Pharmacol 79 1674 1683 1:CAS:528: DC%2BC3cXjvFKmt7Y%3D 20144590 10.1016/j.bcp.2010.01.034